U.S. Senate Democrats advance $430 billion climate, drug bill
U.S. Senate Democrats fend off amendments to $430 bln climate and drug bill
This wide-ranging bill, negotiated over several months by Democrats, would allow Medicare to begin negotiating in 2026 with the pharmaceutical industry over prices on a limited number of prescription drug prices as a way of reducing costs. It also would place a $2,000-per-year cap on out-of-pocket medication costs under a Medicare drug program.
Senate Democrats battle to pass $430 billion climate, drug bill
The bill addresses key elements of the president's agenda - tackling climate change, lowering the costs of medication for the elderly and energy, and forcing corporations and the wealthy to pay more taxes.
Senate rules referee readies Dems economic bill
The Senate parliamentarian on Saturday dealt a blow to Democrats’ plan for curbing drug prices but left the rest of their sprawling economic bill largely intact as party leaders prepared for first votes on the package. (Aug. 6)
Senate rules referee weakens Dem drug plan in economic bill
WASHINGTON (AP) — The Senate parliamentarian on Saturday dealt a blow to Democrats’ plan for curbing drug prices but left the rest of their sprawling economic bill largely intact as party leaders prepared for first votes on a package containing many of President Joe Biden's top domestic goals.
Senate Democrats clear procedural hurdle on marquee tax and spending bill
Senate Democrats on Saturday cleared a key procedural hurdle on the path toward passing their $740 billion health care, climate, tax and spending package, setting up a significant win for the party after months of tense back-and-forth over the cornerstone bill in President Biden’s long-stalled legislative agenda.
- 64% of the sources are Center
To view factuality data please Upgrade to Premium
To view ownership data please Upgrade to Vantage